OXiGENE Inc. (OXGN) News

News for OXiGENE Inc. (OXGN)

Sector News | Topic News

After Hours: $ 1.20

-0.02 (-1.64%)

Volume: 874

4:15 PM EST Feb 10, 2012

Tue, Feb 07, 2012

8:20 AM

Biotech Sector Shows No Signs of Slowing -- OXiGENE and Generex Poised for Growth - Marketwire

Mon, Feb 06, 2012

8:01 AM

OXiGENE to Present at BIO CEO & Investor Conference - Globe Newswire

Mon, Dec 12, 2011

8:00 AM

OXiGENE and Azanta A/S Establish Partnership to Provide ZYBRESTAT(TM) for ATC in Europe on Named Patient, Compassionate Use Basis - Globe Newswire

Wed, Dec 07, 2011

8:00 AM

OXiGENE Presents Data From FAVOR Study of ZYBRESTAT in PCV - Globe Newswire

Mon, Dec 05, 2011

8:16 AM

Marina Biotech and OXiGENE Supported by Strong Clinical Programs - Marketwire

Tue, Nov 29, 2011

7:05 AM

MerrillEquities.com Issues Trading Outlook on Hottest Stocks in Today's Market: DEXO, OXGN, GALE - Accesswire

Mon, Nov 28, 2011

8:30 AM

OXiGENE Announces Purchase Agreement for Up to $20 Million With Lincoln Park Capital - Globe Newswire

Wed, Nov 09, 2011

4:01 PM

OXiGENE Reports Third Quarter 2011 Financial Results - Globe Newswire

Thu, Nov 03, 2011

4:30 PM

OXiGENE Reports Final Data From Phase 2 FALCON Study of ZYBRESTAT in Non-Small Cell Lung Cancer - Globe Newswire

Wed, Nov 02, 2011

7:00 AM

OXiGENE Announces Third Quarter 2011 Earnings Conference Call and Webcast - Globe Newswire

Fri, Oct 21, 2011

8:16 AM

OXiGENE and Neoprobe Reawaken Investor Interest in Biotechnology Industry - Marketwire

Wed, Sep 14, 2011

1:18 PM

OXiGENE Presents Data Confirming Survival Benefit of ZYBRESTAT in Patients With Anaplastic Thyroid Cancer - Globe Newswire

Fri, Sep 09, 2011

4:00 PM

OXiGENE Announces Changes to Board of Directors - Globe Newswire

Wed, Sep 07, 2011

4:34 PM

OXiGENE to Present Additional ZYBRESTAT(TM) Survival Data at European Thyroid Association Annual Meeting - Globe Newswire

8:16 AM

Marina Biotech and OXiGENE Attack Cancer From Different Angles - Marketwire

Thu, Sep 01, 2011

8:00 AM

OXiGENE Announces Restructuring to Focus Resources on Promising Earlier Stage Clinical Programs - Globe Newswire

Wed, Aug 10, 2011

4:01 PM

OXiGENE Reports Second Quarter 2011 Financial Results - Globe Newswire

Wed, Jun 15, 2011

8:16 AM

Ariad and OXiGENE Show Encouraging Growth Potential - Marketwire

Mon, Jun 06, 2011

4:45 PM

ZYBRESTAT(TM) Results Suggest Improvement in Overall Survival in Phase 2/3 Study in Anaplastic Thyroid Cancer - Globe Newswire

8:00 AM

OXiGENE Complies With NASDAQ Listing Requirements - Globe Newswire

Sat, Jun 04, 2011

3:00 PM

OXiGENE Reports Encouraging Data From Phase 2 Trial of ZYBRESTAT(TM) in Non-small Cell Lung Cancer - Globe Newswire

Wed, May 18, 2011

8:01 AM

OXiGENE Announces Clinical Data From FACT and FALCON Studies to be Presented at ASCO - Globe Newswire

Thu, May 12, 2011

4:02 PM

OXiGENE Reports First Quarter 2011 Financial Results - Globe Newswire

8:00 AM

OXiGENE Announces Initiation of Phase 1 Trial of OXi4503 in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome - Globe Newswire

Tue, May 10, 2011

9:01 AM

Global Conditions to Influence Pharmaceuticals -- Industry Report Featuring OXiGENE and Merck & Co., Inc. - Marketwire

First

1 2

Last